Pre-Open Stock Movers 11/5: (BIGC) (EXPE) (PFE) Higher; (PTON) (MRNA) (MRK) Lower (more...)

Moderna (MRNA) Requests to Expand Conditional Marketing Authorization for its COVID-19 Vaccine in the EU to Include Children Ages 6-11 Years

Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for a variation to the conditional marketing authorization (CMA) with the European Medicines Agency (EMA) for the evaluation of a 50 µg two-dose series of mRNA-12731 in children ages 6-11 years.

We are pleased to announce the submission of this variation to the EMA for use of our COVID-19 vaccine in children ages 6-11 in the... More

Merck (MRK) and Ridgeback Announce Additional Purchase of 1.4M Courses of Molnupiravir by the US Government

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United States government will exercise two of its options to purchase a total of 1.4 million additional courses of molnupiravir, an investigational oral antiviral medicine, if the medicine is granted Emergency Use Authorization (EUA) or approval by the U.S. Food and Drug Administration (FDA), for approximately $1 billion. With these exercised options, the U.S. government has now committed to purchase a total of approximately 3.1 million courses of molnupiravir, for approximately $2.2 billion, between authorization and... More

Merck (MRK) Acquisition of Acceleron Pharma Cleared by Antitrust Authorities in Germany and Austria

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition authorities in Germany and Austria.

As previously announced on October 12, 2021, Merck commenced, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron, for $180 in cash, without interest and less any required tax withholding. The receipt of antitrust clearance from the competition authorities in Germany and Austria satisfies one of the... More

Merck (MRK) ahead of Pfizer (PFE) in EU talks on COVID-19 pills -EU source - Reuters

Merck (NYSE: MRK) ahead of Pfizer (NYSE: PFE) in EU talks on COVID-19 pills -EU source - Reuters

Datadog (DDOG) PT Raised to $236 at Needham & Company

Needham & Company analyst Jack Andrews raised the price target on Datadog (NASDAQ: DDOG) to $236.00 (from $173.00) while maintaining a Buy rating.

The analyst commented, "DDOG reported another extraordinarily strong quarter in 3Q21, highlighted by accelerating growth at increasing scale, and management updated FY21... More

Moderna (MRNA) Hits Low, Down 25% on Session

Moderna (NASDAQ: MRNA) Hits Low, Down 25% on Session